Perhaps the biggest bombshell was a separate announcement saying that Moderna’s vaccine can be stored at 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit) for 30 days. That’s the temperature found in a normal refrigerator or in a cooler filled with ice. This feature may give Moderna an edge because it makes mass distribution less challenging in rural areas and low-income countries.
The reason Moderna’s vaccine is more durable in regular refrigeration because its scientists have figured out how to keep it more stable. That was accomplished by mastering a strategic formula of lipid nanoparticles—the structural backbone of the vaccine that doubles as a mode of transporting the drug into human cells, says Aliasger K. Salem, chair of pharmaceutical sciences at the University of Iowa. While the details of Moderna’s science are proprietary, Salem says the company’s COVID-19 vaccine likely builds on its previous work using lipid nanoparticles in immunizations for other infectious diseases, such as respiratory syncytial virus.